BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant
ANAHEIM, CA, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of...
Day: October 7, 2021
ALR Technologies Releases New Website and Investor Presentation
SINGAPORE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ALR Technologies (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today...
Pliant Therapeutics to Participate in Piper Sandler Lung Day
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company...
Avid Bioservices Appoints Matthew Kwietniak as Chief Commercial Officer
Accomplished Senior Executive with Nearly 30 Years of Sales Experience Spanning CDMO Offerings, Clinical Development Services and Scientific ProductsTUSTIN, Calif.,...
Outlook Therapeutics to Present at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting
Suber Huang, MD, MBA, FASRS, will present safety data from Outlook Therapeutics’ NORSE THREE registration trial on Tuesday, October 12,...
Editas Medicine to Present Preclinical Data on Novel Engineered iPSC Derived NK Cells for the Treatment of Cancer at the Society for Immunotherapy of Cancer 36th Annual Meeting
CAMBRIDGE, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced...
iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)
Leading-edge AI solution for 2D mammography enhances cancer detection performance for clinicians, with improved sensitivity, specificity, and processing times over...
Clearmind Medicine Partners With Clinipace to Commence Processes Towards FDA Approval
The Regulatory affairs and CRO will oversee the Company’s efforts to secure an IND review of MEAI as a potential...
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol “SNCE”Business combination will provide Science 37...
Jounce Therapeutics Progresses INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and Pimivalimab (PD-1 Inhibitor) Combination Therapy in Patients with Advanced Solid Tumors
- Enrollment initiated in tumor-specific monotherapy and pimivalimab combination expansion cohorts – - Monotherapy and pimivalimab combination dose escalation enrollment...
Oculis Appoints Dr. Joanne Chang as Global Chief Medical Officer and Opens Hong Kong Office to broaden its footprint and build a strong Asia/China presence
- Dr. J. Chang, former Novartis Global Medical Affairs Head, Ophthalmology, to lead the advancement and expansion of Oculis’ pipeline...
Xealth and Banner Health Showcasing Digital Health Success at Cerner Health Conference 2021
SEATTLE--(BUSINESS WIRE)--#CHC21--Xealth, the leader in enabling digital health at scale, today announced its participation with Banner Health in the Cerner...
NextGen Virtual Visits and NextGen Mobile Leveraged by Mednax® to Expand Access to Care
Prominent Nationwide Provider Adopts Fully Integrated Healthcare Platform ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused...
Axonics® to Report Third Quarter 2021 Financial Results on November 4
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
Dr. Vijay Magon named as a One To Watch in The LDC Top 50 Most Ambitious Business Leaders programme 2021
October 7, 2021 – CCube Solutions announces today that its founder and managing director, Dr. Vijay Magon, has been named...
AiCuris Announces Opening of Second Round of AiCubator Corporate Innovation Accelerator Initiative to Propel Anti-infective Drug Development
AiCubator was launched by AiCuris in 2020 to provide long-term support for early but promising research projects in the field...
Xlife Sciences AG: Successful License Deal with Vitese Trading GmbH
Inflamed pharma GmbH signs license agreement with Vitesse Trading GmbHZURICH, SWITZERLAND / ACCESSWIRE / October 7, 2021 / The Xlife-project...